Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
Authors
Keywords
-
Journal
International Journal of Nanomedicine
Volume Volume 16, Issue -, Pages 457-467
Publisher
Informa UK Limited
Online
2021-01-15
DOI
10.2147/ijn.s283793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System
- (2020) Maria Chountoulesi et al. Brain Sciences
- Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer
- (2019) Vijay S. Madamsetty et al. Nanomedicine-Nanotechnology Biology and Medicine
- Reversible Shielding between Dual Ligands for Enhanced Tumor Accumulation of ZnPc-Loaded Micelles
- (2019) Jing Cao et al. NANO LETTERS
- Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects
- (2019) Hong Jiang et al. International Journal of Nanomedicine
- Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors
- (2019) Shengcai Yang et al. ADVANCED MATERIALS
- Promoting Early Diagnosis and Precise Therapy of Hepatocellular Carcinoma by Glypican-3-Targeted Synergistic Chemo-Photothermal Theranostics
- (2019) Weiwei Mu et al. ACS Applied Materials & Interfaces
- Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs
- (2019) Yaelle Bavli et al. JOURNAL OF CONTROLLED RELEASE
- Smart Nanotherapeutic Targeting of Tumor Vasculature
- (2019) Zifu Li et al. ACCOUNTS OF CHEMICAL RESEARCH
- Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma
- (2019) Taofeng Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment
- (2019) Na Shen et al. NANO LETTERS
- Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma
- (2018) Shulong Jiang et al. CARBOHYDRATE POLYMERS
- Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes
- (2018) Jian Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
- (2018) David A. Mahvi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration
- (2018) Yike Huang et al. International Journal of Nanomedicine
- Recent advances in hepatocellular carcinoma therapy
- (2017) Rinku Dutta et al. PHARMACOLOGY & THERAPEUTICS
- GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment
- (2017) Quan Zhou et al. Scientific Reports
- Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
- (2016) Bora Jang et al. ADVANCED DRUG DELIVERY REVIEWS
- “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy
- (2016) Jessica A. Kemp et al. ADVANCED DRUG DELIVERY REVIEWS
- Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy
- (2016) Bo Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Local iontophoretic administration of cytotoxic therapies to solid tumors
- (2015) James D. Byrne et al. Science Translational Medicine
- Broad targeting of angiogenesis for cancer prevention and therapy
- (2015) Zongwei Wang et al. SEMINARS IN CANCER BIOLOGY
- Graphene as Cancer Theranostic Tool: Progress and Future Challenges
- (2015) Marco Orecchioni et al. Theranostics
- Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice
- (2014) Yan Zou et al. JOURNAL OF CONTROLLED RELEASE
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model
- (2012) Femke Heindryckx et al. JOURNAL OF HEPATOLOGY
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
- (2010) Amir Abdollahi et al. DRUG RESISTANCE UPDATES
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started